# Biomat USA, Inc. – FDA Inspection, Dec 13, 2024

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/3d2596d9-c59c-4357-ba91-21c438e15d5f
Source feed: FDA_Inspections

> FDA inspection 1256896 of Biomat USA, Inc., December 13, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1256896
- Company Name: Biomat USA, Inc.
- Inspection Date: 2024-12-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Detroit District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1094894 - 2019-06-06
- FDA Inspection 945499 - 2015-09-18
- [FDA Inspection 745721 - 2011-09-20](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/75a1483f-2a61-4661-84b0-11d22d24148e)
- FDA Inspection 573575 - 2009-03-25

## Related Officers

- [Investigator](https://www.keypedia.com/people/david-a-moore/361e4fe8-caf0-4320-963a-3838616850e2)
- [Investigator](https://www.keypedia.com/people/lesley-mae-p-lutao/bfdcc755-28e5-4caf-91f9-b9579df4731e)

Company: https://www.keypedia.com/companies/biomat-usa-inc/3f431465-eedc-461b-adf4-3aa8816d34f0

Office: https://www.keypedia.com/offices/detroit-district-office/b09a1815-a000-40c0-bb44-5432ce87ed03
